- Home
- COFS vs RGNX Comparison
COFS vs RGNX Comparison
Compare COFS & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COFS
- RGNX
- Stock Information
- Founded
- COFS 1898
- RGNX 2008
- Country
- COFS United States
- RGNX United States
- Employees
- COFS N/A
- RGNX N/A
- Industry
- COFS Major Banks
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COFS Finance
- RGNX Health Care
- Exchange
- COFS Nasdaq
- RGNX Nasdaq
- Market Cap
- COFS 443.2M
- RGNX 451.1M
- IPO Year
- COFS N/A
- RGNX 2015
- Fundamental
- Price
- COFS $27.90
- RGNX $12.54
- Analyst Decision
- COFS Strong Buy
- RGNX Strong Buy
- Analyst Count
- COFS 2
- RGNX 8
- Target Price
- COFS $39.00
- RGNX $28.50
- AVG Volume (30 Days)
- COFS 84.6K
- RGNX 525.7K
- Earning Date
- COFS 10-22-2025
- RGNX 11-05-2025
- Dividend Yield
- COFS 3.93%
- RGNX N/A
- EPS Growth
- COFS N/A
- RGNX N/A
- EPS
- COFS 1.30
- RGNX N/A
- Revenue
- COFS $108,378,000.00
- RGNX $155,782,000.00
- Revenue This Year
- COFS $77.76
- RGNX $203.79
- Revenue Next Year
- COFS $8.17
- RGNX $0.72
- P/E Ratio
- COFS $21.96
- RGNX N/A
- Revenue Growth
- COFS 30.36
- RGNX 74.95
- 52 Week Low
- COFS $24.89
- RGNX $5.04
- 52 Week High
- COFS $38.15
- RGNX $12.28
- Technical
- Relative Strength Index (RSI)
- COFS 33.67
- RGNX 76.51
- Support Level
- COFS $27.90
- RGNX $10.24
- Resistance Level
- COFS $29.00
- RGNX $11.00
- Average True Range (ATR)
- COFS 0.75
- RGNX 0.63
- MACD
- COFS -0.15
- RGNX 0.28
- Stochastic Oscillator
- COFS 4.32
- RGNX 92.36
About COFS ChoiceOne Financial Services Inc.
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.